Related references
Note: Only part of the references are listed.Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis
M. V. Dieci et al.
ANNALS OF ONCOLOGY (2013)
Neoadjuvant therapy for ER-positive breast cancers
M. Colleoni et al.
ANNALS OF ONCOLOGY (2012)
Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy
Nehmat Houssami et al.
EUROPEAN JOURNAL OF CANCER (2012)
PET Imaging of Estrogen Receptors as a Diagnostic Tool for Breast Cancer Patients Presenting with a Clinical Dilemma
Michel van Kruchten et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Accuracy of Clinical Examination, Digital Mammogram, Ultrasound, and MRI in Determining Postneoadjuvant Pathologic Tumor Response in Operable Breast Cancer Patients
Randal Croshaw et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Between-Patient and Within-Patient (Site-to-Site) Variability in Estrogen Receptor Binding, Measured In Vivo by 18F-Fluoroestradiol PET
Brenda F. Kurland et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
S. J. Aitken et al.
ANNALS OF ONCOLOGY (2010)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Predictors of complete pathological response after neoadjuvant systemic therapy for breast cancer
Marcus C. Tan et al.
AMERICAN JOURNAL OF SURGERY (2009)
PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer
Farrokh Dehdashti et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Preoperative [18F] FDG-PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathology
J. Emmering et al.
ANNALS OF ONCOLOGY (2008)
Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
Mei-Lin W. Ah-See et al.
CLINICAL CANCER RESEARCH (2008)
18F-fluoroestradiol
Lavanya Sundararajan et al.
SEMINARS IN NUCLEAR MEDICINE (2007)
Semi-automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer
G. M. Sharangpani et al.
JOURNAL OF MICROSCOPY (2007)
Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography
Caroline Rousseau et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Molecular classification of breast cancer: Limitations and potential
Lajos Pusztai et al.
ONCOLOGIST (2006)
Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer
Martin D. Pickles et al.
MAGNETIC RESONANCE IMAGING (2006)
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer
Hannah M. Linden et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27
HD Bear et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Automatic synthesis of 16α-[18F]fluoro-17β-estradiol using a cassette-type [18F]fluorodeoxyglucose synthesizer
T Mori et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)
Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy
SJ Kim et al.
ANNALS OF ONCOLOGY (2004)
Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography
RJ Burcombe et al.
EUROPEAN JOURNAL OF CANCER (2002)
Meeting highlights: International consensus panel on the treatment of primary breast cancer
A Goldhirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Positron emission tomography using [18F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy
IC Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
